Amgen Seeks To Hold Off Generics In FDA Denial Challenge
Amgen Inc. on Monday asked a D.C. federal judge to order the U.S. Food and Drug Administration to temporarily refrain from approving any generic versions of its blockbuster drug Sensipar while...To view the full article, register now.
Already a subscriber? Click here to view full article